Jeff Auxier's PFE Position Overview
Jeff Auxier (via Auxier Asset Management LLC) currently holds 60,909 shares of Pfizer Inc. (PFE) worth $1.52 M, representing 0.21% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Jeff Auxier has maintained a long-term strategic position in PFE, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2020, adding 11,405 shares. Largest reduction occurred in Q1 2015, reducing 45,749 shares.
Analysis based on 13F filings available since 2013 Q2
Jeff Auxier's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Jeff Auxier
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -3,830 | Reduce 5.92% | 60,909 | $24.90 |
| Q3 2025 | -600 | Reduce 0.92% | 64,739 | $25.48 |
| Q2 2025 | +281 | Add 0.43% | 65,339 | $24.24 |
| Q1 2025 | -470 | Reduce 0.72% | 65,058 | $25.34 |
| Q4 2024 | -2,725 | Reduce 3.99% | 65,528 | $26.53 |
| Q3 2024 | -525 | Reduce 0.76% | 68,253 | $28.94 |
| Q2 2024 | +243 | Add 0.35% | 68,778 | $27.98 |
| Q1 2024 | -2,995 | Reduce 4.19% | 68,535 | $27.75 |
| Q4 2023 | -570 | Reduce 0.79% | 71,530 | $28.79 |
| Q3 2023 | -250 | Reduce 0.35% | 72,100 | $33.17 |
| Q2 2023 | +4,664 | Add 6.89% | 72,350 | $36.68 |
| Q1 2023 | +670 | Add 1.00% | 67,686 | $40.80 |
| Q4 2022 | -850 | Reduce 1.25% | 67,016 | $51.24 |
| Q3 2022 | -1,562 | Reduce 2.25% | 67,866 | $43.76 |
| Q2 2022 | -790 | Reduce 1.13% | 69,428 | $52.43 |
| Q1 2022 | -4,955 | Reduce 6.59% | 70,218 | $51.77 |
| Q4 2021 | -598 | Reduce 0.79% | 75,173 | $59.05 |
| Q3 2021 | -650 | Reduce 0.85% | 75,771 | $43.01 |
| Q2 2021 | -2,930 | Reduce 3.69% | 76,421 | $39.16 |
| Q1 2021 | -5,675 | Reduce 6.67% | 79,351 | $36.23 |
| Q4 2020 | -100 | Reduce 0.12% | 85,026 | $36.81 |
| Q3 2020 | +453 | Add 0.53% | 85,126 | $36.70 |
| Q2 2020 | +11,405 | Add 15.57% | 84,673 | $32.70 |
| Q1 2020 | -897 | Reduce 1.21% | 73,268 | $32.63 |
| Q4 2019 | -836 | Reduce 1.11% | 74,165 | $39.18 |
| Q3 2019 | +21 | Add 0.03% | 75,001 | $35.93 |
| Q2 2019 | +1,775 | Add 2.42% | 74,980 | $43.32 |
| Q1 2019 | +1,125 | Add 1.56% | 73,205 | $42.47 |
| Q4 2018 | -3,800 | Reduce 5.01% | 72,080 | $43.65 |
| Q3 2018 | -300 | Reduce 0.39% | 75,880 | $44.07 |
| Q2 2018 | -2,100 | Reduce 2.68% | 76,180 | $36.28 |
| Q1 2018 | -338 | Reduce 0.43% | 78,280 | $35.49 |
| Q4 2017 | -2,450 | Reduce 3.02% | 78,618 | $36.23 |
| Q3 2017 | -4,600 | Reduce 5.37% | 81,068 | $35.70 |
| Q2 2017 | +800 | Add 0.94% | 85,668 | $33.59 |
| Q1 2017 | -625 | Reduce 0.73% | 84,868 | $34.21 |
| Q4 2016 | +478 | Add 0.56% | 85,493 | $32.48 |
| Q3 2016 | -884 | Reduce 1.03% | 85,015 | $33.86 |
| Q1 2016 | -325 | Reduce 0.38% | 85,899 | $29.64 |
| Q4 2015 | -98 | Reduce 0.11% | 86,224 | $32.28 |
| Q2 2015 | -12,607 | Reduce 12.74% | 86,322 | $33.53 |
| Q1 2015 | -45,749 | Reduce 31.62% | 98,929 | $34.79 |
| Q4 2014 | -950 | Reduce 0.65% | 144,678 | $31.15 |
| Q3 2014 | -28 | Reduce 0.02% | 145,628 | $29.57 |
| Q2 2014 | -225 | Reduce 0.15% | 145,656 | $29.68 |
| Q1 2014 | -13,443 | Reduce 8.44% | 145,881 | $32.12 |
| Q4 2013 | -7,550 | Reduce 4.52% | 159,324 | $30.63 |
| Q2 2013 | +166,875 | Add 0.00% | 166,874 | $28.01 |
Jeff Auxier's Pfizer Investment FAQs
Jeff Auxier first purchased Pfizer Inc. (PFE) in Q2 2013, acquiring 166,874 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier has held Pfizer Inc. (PFE) for 51 quarters since Q2 2013.
Jeff Auxier's largest addition to Pfizer Inc. (PFE) was in Q2 2013, adding 166,874 shares worth $4.67 M.
According to the latest 13F filing for Q4 2025, Jeff Auxier's firm, Auxier Asset Management LLC, owns 60,909 shares of Pfizer Inc. (PFE), valued at approximately $1.52 M.
As of the Q4 2025 filing, Pfizer Inc. (PFE) represents approximately 0.21% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings.
Jeff Auxier's peak holding in Pfizer Inc. (PFE) was 166,874 shares, as reported at the end of Q2 2013.